Compounds > naltrexone

naltrexone and Alveolar Bone Atrophy

naltrexone has been researched along with Alveolar Bone Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
D'Ângelo, MQ; Ferreira, AJ; Maltos, KLM; Pacheco, CMDF; Queiroz-Junior, CM; Soares, RV1
Caliari, MV; Francischi, JN; Maltos, KL; Pacheco, CM; Queiroz, CM; Rocha, OA1

Other Studies

2 other study(ies) available for naltrexone and Alveolar Bone Atrophy

ArticleYear
The blockade of kappa opioid receptors exacerbates alveolar bone resorption in rats.
    Archives of oral biology, 2020, Volume: 120

    Topics: Alveolar Bone Loss; Animals; Bone Resorption; Cytokines; Disease Models, Animal; Male; Morphinans; Naltrexone; Narcotic Antagonists; Osteoblasts; Osteoclasts; Periodontitis; Rats; Rats, Wistar; Receptors, Opioid

2020
Local opioids in a model of periodontal disease in rats.
    Archives of oral biology, 2007, Volume: 52, Issue:7

    Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gingiva; Injections; Injections, Subcutaneous; Leukocyte Count; Male; Morphine; Naltrexone; Narcotic Antagonists; Neutrophils; Periodontal Attachment Loss; Periodontal Diseases; Rats; Rats, Sprague-Dawley; Receptors, Opioid

2007